These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Safety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in Tanzania. Mwaiswelo R, Ngasala BE, Jovel I, Gosling R, Premji Z, Poirot E, Mmbando BP, Björkman A, Mårtensson A. Malar J; 2016 Jun 10; 15():316. PubMed ID: 27287612 [Abstract] [Full Text] [Related]
4. Primaquine or other 8-aminoquinolines for reducing Plasmodium falciparum transmission. Graves PM, Choi L, Gelband H, Garner P. Cochrane Database Syst Rev; 2018 Feb 02; 2(2):CD008152. PubMed ID: 29393511 [Abstract] [Full Text] [Related]
5. Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission. Graves PM, Gelband H, Garner P. Cochrane Database Syst Rev; 2015 Feb 19; (2):CD008152. PubMed ID: 25693791 [Abstract] [Full Text] [Related]
6. Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission. Graves PM, Gelband H, Garner P. Cochrane Database Syst Rev; 2014 Jun 30; (6):CD008152. PubMed ID: 24979199 [Abstract] [Full Text] [Related]
8. The effect of single low-dose primaquine treatment for uncomplicated Plasmodium falciparum malaria on haemoglobin levels in Ethiopia: a longitudinal cohort study. Habtamu K, Getachew H, Abossie A, Demissew A, Tsegaye A, Degefa T, Wang X, Lee MC, Zhou G, Kibret S, King CL, Kazura JW, Petros B, Yewhalaw D, Yan G. Malar J; 2024 Jul 12; 23(1):208. PubMed ID: 38997771 [Abstract] [Full Text] [Related]
16. Development of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study. Poirot E, Soble A, Ntshalintshali N, Mwandemele A, Mkhonta N, Malambe C, Vilakati S, Pan S, Darteh S, Maphalala G, Brown J, Hwang J, Pace C, Stergachis A, Vittinghoff E, Kunene S, Gosling R. Malar J; 2016 Jul 22; 15(1):384. PubMed ID: 27450652 [Abstract] [Full Text] [Related]
17. Single Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects. Bancone G, Chowwiwat N, Somsakchaicharoen R, Poodpanya L, Moo PK, Gornsawun G, Kajeechiwa L, Thwin MM, Rakthinthong S, Nosten S, Thinraow S, Nyo SN, Ling CL, Wiladphaingern J, Kiricharoen NL, Moore KA, White NJ, Nosten F. PLoS One; 2016 Jul 22; 11(3):e0151898. PubMed ID: 27010542 [Abstract] [Full Text] [Related]
18. CYP2D6 Polymorphisms and the Safety and Gametocytocidal Activity of Single-Dose Primaquine for Plasmodium falciparum. Pett H, Bradley J, Okebe J, Dicko A, Tiono AB, Gonçalves BP, Stone W, Chen I, Lanke K, Neuvonen M, Mustaniemi AL, Eziefula AC, Gosling R, D'Alessandro U, Drakeley C, Niemi M, Bousema T. Antimicrob Agents Chemother; 2019 Oct 22; 63(10):. PubMed ID: 31383656 [Abstract] [Full Text] [Related]
19. A randomized open-label trial of artesunate- sulfadoxine-pyrimethamine with or without primaquine for elimination of sub-microscopic P. falciparum parasitaemia and gametocyte carriage in eastern Sudan. El-Sayed B, El-Zaki SE, Babiker H, Gadalla N, Ageep T, Mansour F, Baraka O, Milligan P, Babiker A. PLoS One; 2007 Dec 12; 2(12):e1311. PubMed ID: 18074034 [Abstract] [Full Text] [Related]
20. Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, non-inferiority trial. Taylor WR, Olupot-Olupot P, Onyamboko MA, Peerawaranun P, Weere W, Namayanja C, Onyas P, Titin H, Baseke J, Muhindo R, Kayembe DK, Ndjowo PO, Basara BB, Bongo GS, Okalebo CB, Abongo G, Uyoga S, Williams TN, Taya C, Dhorda M, Tarning J, Dondorp AM, Waithira N, Fanello C, Maitland K, Mukaka M, Day NJP. Lancet Infect Dis; 2023 Apr 12; 23(4):471-483. PubMed ID: 36462528 [Abstract] [Full Text] [Related] Page: [Next] [New Search]